
News|Articles|May 1, 2002
Stavudine: Lactic acidosis, motor weakness warnings
Bristol-Myers Squibb has issued a "Dear Healthcare Provider" letter and revised labeling to inform of the potential for lactic acidosis and severe hepatomegaly with steatosis-including some fatal cases-when nucleoside analogue therapy is used alone or in combination with other antiretrovirals
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
2
Judi Health, Employers Health team up to launch new PBM solution
3
Brandon Kessler on pharmacy pricing under CAA 2026 | PBMI 2026
4
Amy Wadstrom, RPh, on mid-size PBMs and leaving the ‘big three’ | PBMI 2026
5
















